Author

I. Delgado

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Lamas· 1 shared A. Maruri· 1 shared A. Rago· 1 shared C. Banister· 1 shared C. Garcia-Duran· 1 shared C. Gil· 1 shared C. Liu· 1 shared C. Luna-Paredes· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Lamas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Statistical evaluation of metaproteomics and 16s rRNA amplicon sequencing techniques for the study of the gut microbiota establishment of infants with cystic fibrosis

C. Garcia-Duran, E. Romeu, M. L. Hernaez-Sanchez, A. Maruri, N. Baston-Paz, A. Lamas, S. Vicente, E. Perez-Ruiz, I. Delgado, C. Luna-Paredes, J. de Dios-Caballero, J. Zamora, L. Monteoliva, C. Gil, R. del Campo

This study compares 16S rRNA amplicon sequencing and metaproteomics for analyzing gut microbiota in infants with cystic fibrosis, finding similar taxonomic assignments but discrepancies in abundance detection.

bioRxiv · Apr 18, 2022Microbiology

TP53 knockout in MCF7 breast cancer cells induces sensitivity to fluoropyrimidine drugs.

J. M. Warrington, S. Mehta, V. F. Moy, J. Patel, C. Liu, A. Rago, C. McTighe, I. Delgado, C. Banister, W. Gmeiner, P. J. Buckhaults

This study shows TP53 knockout in breast cancer cells increases sensitivity to fluoropyrimidine drugs like F10, with DNA incorporation as a key mechanism.

bioRxiv · Feb 10, 2022 · PreprintCancer Biology